参考文献/References:
[1]何煦芳,全会标,魏伟平,等.艾塞那肽联合二甲双胍治疗新诊断超重或肥胖2型糖尿病的疗效及后续观察[J].中南医学科学杂志,2017(4):58-59.[2]赵涛,乐静,李传静,等.二甲双胍对2型糖尿病胰岛素抵抗患者糖脂代谢及脂肪因子的影响[J].安徽医药,2017,20(7):1382-1385.[3]李天艺,李华,焦文君,等.二甲双胍对老年2型糖尿病炎症和肠道菌群失衡的临床疗效研究[J].中华老年医学杂志,2018,37(8):879-882.[4]Li Y,Teng D,Shi X,et al.Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the Ameri can Diabetes Association:national cross sectional study[J].BMJ,2020(369):m997.[5]那日苏,刘志文,马聪,等.格列美脲联合沙格列汀治疗2型糖尿病的疗效观察[J].现代药物与临床,2018,33(10):2585-2588.[6]杜少南.双胍类降糖药物对2型糖尿病治疗的临床疗效[J].实用糖尿病杂志,2020,20(12):312-314.[7]杨琼,王炜城.瑞舒伐他汀联合二甲双胍对2型糖尿病并发非酒精性脂肪肝患者肝功能和炎症因子的影响[J].药物评价研究,2020,43(1):107-110.[8]张四青,习燕华,钟树妹,等.格列美脲联合二甲双胍对新诊断2型糖尿病伴非酒精性脂肪肝病患者胰岛素抵抗和胰岛β细胞功能的影响[J].中国全科医学,2017,15(2):489-491.[9]温泉,钟兴,潘天荣,等.达格列净联合二甲双胍治疗2型糖尿病的疗效及对糖脂代谢的影响[J].现代生物医学进展,2020,29(9):372-374.[10]庾更绪,刘洋.双胍类降糖药物对2型糖尿病治疗的临床疗效[J].黑龙江医药科学,2018,15(10):224-226.[11]肖惟丹,袁志超.抗阻力运动联合双胍类降糖药物对2型糖尿病的治疗价值[J].中西医结合心血管病电子杂志,2018,28(8):86-88.[12]郑鹏.二甲双胍肠溶片联合格列齐特缓释片治疗2型糖尿病[J].吉林医药学院学报,2021,16(6):138-140.[13]李法宁,陈原,匡平,等.2种口服降糖药物联合胰岛素治疗初诊2型糖尿病的临床对比研究[J].中国医院药学杂志,2017,6(3):89-90.[14]李凤,翟晨辉,侯志梅.格列美脲对2型糖尿病患者代谢水平及血清IL-1β的影响[J].医学综述,2018,24(1):184-188.[15]李秀梅,杨秀红,董陆玲.西格列汀治疗二甲双胍不耐受的新诊断2型糖尿病临床观察[J].河北医药,2016,38(8):1189-1192.[16]Hwang S,Park J,Kim J,et al.Tissue expression of tubular in jury markers is associated with renal function decline in diabetic nephropathy [J].Journal of Diabetes&Its Complications,2017,31(12):1704-1709.[17]陈超,叶山东,邢学农,等.沙格列汀对2型糖尿病伴正常体重的代谢性肥胖患者体脂成分的影响[J].中国糖尿病杂志,2016,24(8):693-694.[18]王霖霞. 二甲双胍对2型糖尿病骨质疏松骨代谢影响及机制研究[D].石家庄:河北医科大学,2021.
相似文献/References:
[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in
Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(16):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(16):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的
相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(16):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(16):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[5]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(16):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[6]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行
健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Journal of Medical Information,2018,31(16):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
[7]丁 星,赵 畅,张海严,等.麦邦数据远程传输型血糖仪临床测量准确性的评价研究[J].医学信息,2018,31(15):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
DING Xing,ZHAO Chang,ZHANG Hai-yan,et al.Evaluation of Accuracy of Clinical Measurement of Maibang Remote Data Transmission Glucometer[J].Journal of Medical Information,2018,31(16):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
[8]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(16):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[9]刘小红.长效胰岛素联合口服降糖药治疗2型糖尿病的
疗效与安全性评价[J].医学信息,2018,31(18):121.[doi:10.3969/j.issn.1006-1959.2018.18.038]
LIU Xiao-hong.Efficacy and Safety of Long Acting Insulin Combined with Oral Hypoglycemic Agents in Treatment of Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(16):121.[doi:10.3969/j.issn.1006-1959.2018.18.038]
[10]鲍 哲,杨升伟,柯赛赛,等.益生元对2型糖尿病患者糖脂代谢的影响[J].医学信息,2018,31(18):132.[doi:10.3969/j.issn.1006-1959.2018.18.042]
BAO Zhe,YANG Sheng-wei,KE Sai-sai,et al.Effect of Prebiotics on Glucose and Lipid Metabolism in Patients with Type 2 Diabetes mellitus[J].Journal of Medical Information,2018,31(16):132.[doi:10.3969/j.issn.1006-1959.2018.18.042]